Part V
Chapter 29: The Alchemical Body
Estimated reading time: 11 min
The body—our sacred crucible of flesh—is a complex ecosystem shaped by internal rhythms, lived experience, and what we introduce: prescribed medications, supplements, herbs, and non-prescribed substances.
Medical/Legal Caution Medication changes and substance interactions belong under medical guidance from a qualified clinician, not spiritual improvisation.
Do not start, stop, switch, or taper prescribed medication without your prescriber’s guidance; abrupt changes can be dangerous. Abrupt benzodiazepine discontinuation can cause severe withdrawal, including seizures.
Before adding potent herbs (e.g., St. John’s Wort), high-dose supplements (e.g., 5-HTP), or a psychoactive substance, screen the specific combination for medication interactions. Before breathwork built around sustained rapid or forceful ventilation, screen for medical contraindications. If you take lithium, do not combine it with classic psychedelics.1
Let prescribers and facilitators work from the same honest medication list.
For a detailed medication-interaction checklist (including serotonin syndrome red flags), see the Checklists and Materials appendix.
Conventional medicine offers powerful tools for supporting physical and mental health. For many on the Spiral Path, these interventions are vital: the stability they provide makes integration possible.
On the Dragon’s Path, regulation is foundational: the capacity to return to the body, recover contact, and choose from the Serene Center instead of reflex. The work also requires tracking how these interventions interact with emotion, charge, perception, and altered states. That intersection asks for informed choice, plain speech with prescribers and facilitators, and a refusal of purity culture.
Neurochemistry and Medication
Modern psychotropics influence neurotransmitters—the chemical messengers that help coordinate mood, threat response, attention, sleep, and learning.
Medication alters the terrain practice must move through. It can shift how the Form Body metabolizes stress, how the Eros Body circulates charge, and how the nervous system supports attention and focus.
These energetic terms are felt translations of effects, not medical explanations or guidance for changing treatment.
A dose change or switch can alter the practice floor. Effects vary by medicine, dose, timing, health context, and person.2 Some people experience temporary blunting of sensation or emotion, creating numbness or distance from the body that can resemble dissociation.
If this happens, do not treat it as a spiritual failure or a character flaw. Treat it as information: slow down, emphasize simple grounding, and collaborate with your prescriber. Sometimes it takes time for embodied connection to return as the nervous system adapts and the regimen stabilizes. From there, the practical question is not purity, but what chemistry is shaping the body through which you practise.
For many, the most important effect is stability—the condition that enables deeper practice and integration.
Antidepressants
SSRIs inhibit serotonin reuptake; SNRIs inhibit both serotonin and norepinephrine reuptake. By changing this signalling, they can support mood and anxiety regulation. For many, this is the ground that makes daily functioning and sustained practice possible at all.
In the Dragon’s Path language, they can reduce the baseline noise of anxiety and depressive spirals, widening the window in which regulation is possible. For some, this makes tenderness, beauty, libido, and relational warmth more reachable. Others report emotional or sexual blunting—a “thickening of the veil” in which peaks and the Lover current feel quieter.3 Residual depression can feel similar, so the experience alone does not identify its cause. Neither response is a spiritual failure. The question is whether the treatment’s benefits and trade-offs support a life the person can inhabit.
Benzodiazepines
Benzodiazepines increase the effect of GABA at GABA-A receptors. They can reduce acute anxiety and cause sedation. In acute spikes of terror or panic, short-term, medically supervised use can prevent overwhelm long enough for other supports to return.
Energetically, they can act as an acute brake for the Form Body. Their uses, benefits, and risks vary by medicine, dose, duration, other substances, and person. The class carries risks of sedation, misuse, addiction, physical dependence, and withdrawal; physical dependence is not the same as addiction, and abrupt reduction can be dangerous.4 Some people also experience muted bodily or emotional signals, which can make the Form Body’s danger cues, the Eros Body’s desire signal, or the Soul Body’s discernment harder to read.
Stimulants
Stimulants used for ADHD increase dopamine and norepinephrine signalling and can improve focus and impulse control. For many, they are what makes consistent attention, study, and practice actually possible.
On this map, they can sharpen the Sage’s lens and help the Magician hold a single thread of intention without it fraying. Some people feel calmer and more able to regulate; others experience appetite loss, sleep disruption, irritability, or a keyed-up feeling. Dose, timing, sleep, food, load, and the specific medicine all shape that trade-off; discuss adjustments with your prescriber.
The Energetic Cost: Overclocking
In computing, overclocking forces a processor to run faster than designed: more speed, more heat. For many ADHD nervous systems, prescribed stimulants are less “overclocking” than restoring baseline regulation—a more reliable clock. Overclocking is when stimulants are used to override sleep, ignore the body’s signals, or carry an unrealistic load. Without enough “cooling” (rest, protein, hydration, realistic load), the system burns out. If survival keeps requiring chemical override, the load itself belongs in the inquiry.The same distortion can happen in spiritual life: support that helps honest capacity is one thing; using stimulation to force practice, productivity, or transcendence past real limits is another form of overclocking.
Antipsychotics
Antipsychotics modify dopamine signalling, often via D2 receptors, and are used in clinical care for conditions such as psychosis, mania, and severe mood or thought disturbance. When they help anchor perception toward shared reality, they can make safer practice and deliberate integration possible.
Energetically, they can act as a strong anchor for the Form Body when perception is destabilized. Some people mainly experience relief from agitation or hallucinations. Others also experience sedation or difficulty concentrating, which can make consciousness feel heavier or more distant.5 The balance differs across medicines, doses, conditions, and people. When these medications restore contact with shared reality, that stability can be the prerequisite for safe practice.
Mood Stabilizers
Mood stabilizers such as lithium or valproate are often used to reduce extreme mood swings in bipolar disorder and related mood instability. Smoothing extreme highs and lows can make it possible to sustain practice, relationships, and commitments over time rather than cycling between overreach and collapse.
In energetic terms, they can temper the Creator–Destroyer cycle, reducing the force of manic inflation or depressive collapse so the vertical axis becomes more navigable and the Axis of Being remains more available. What that steadiness feels like is individual. Track changes in energy, cognition, or emotional range in plain language and bring them to the prescriber rather than treating one person’s experience as a property of the whole class.
Medication is part of the Form Body’s ecology, shaping the terrain rather than blocking the path.
The task is conscious integration: recognizing that a stable nervous system is part of the vessel that helps hold Dragon’s Fire.
Practice Alongside Medication
Experiences vary widely; for many, the stability medication provides is what makes this work possible.
Emotional peaks and intensity: Catharsis, grief work, or ecstatic practice depend on access to feeling. Some on SSRIs/SNRIs notice dampened peaks; others find this modulation is precisely what makes deeper practice safer.
Let practice take a different shape: quieter grief work, less peak intensity, steadier contact.
Altered states and interactions: Intensive meditation and high-ventilation breathwork built around sustained rapid or forceful breathing can destabilize some nervous systems or be unsafe in certain conditions. Classic psychedelics, MDMA, ketamine, cannabis, and other psychoactive substances do not share one interaction profile. Some combinations with medications or supplements can be medically dangerous or life-threatening; others change intensity, duration, or predictability. Screen the specific substance and regimen with the prescriber, and give any facilitator the same accurate medication list. Treat the Checklists and Materials appendix as a screen, not permission.
Stimulants and stillness: Some experience difficulty settling while stimulants are active; many others gain meditative traction through improved focus. Choose practice windows, grounding methods, and practice types that fit the prescribed regimen; do not change dose or timing without your prescriber.
Libido and intimacy: Reduced libido can occur for some on antidepressants. Meet changes with compassion and communication; diversify intimacy; discuss options with your prescriber.
Stability often comes first.
Visionary experiences and antipsychotics: Because these medicines are intended to reduce hallucinations and related psychotic symptoms, they can also alter experiences someone has interpreted as visionary. This is not a universal loss of imagination or spiritual capacity; subjective effects vary by medicine, dose, condition, and person.
For those who need them, grounding and discernment are the priority—essential capacities on any path, especially when intensity or altered states are in the mix.
Benzodiazepine dependence and misuse risk: Tolerance and physical dependence can develop, especially with ongoing use. Preventing misuse, monitoring dependence, and planning any taper all belong with the prescriber.
Withdrawal, tapering, and rebound effects: Depending on the medicine and the change, withdrawal or rebound can include anxiety, sleep disturbance, sensory symptoms, fatigue, mood changes, agitation, or more severe destabilization. Do not mistake that weather for a dark night, moral failure, or proof that your path has collapsed. Treat it as physiology first. Slow down interpretation; protect sleep, food, steady human support, and medical guidance.
The aim is to discover the combination of supports that sustains your capacity, without chasing an idealized notion of purity or “untainted” experience.
Shared Medical Truth
Medicine, practice, and facilitation have to share one truth: what the body is actually carrying.
Each may speak a different language. Honesty lets them meet without making the body carry the risk.
When those conversations split apart, the body absorbs the confusion and the risk rises.
Start with your own honesty: stability comes before idealized intensity. Bring your prescriber the actual practice or altered-state work you are considering, and ask plainly about interactions, pacing, and what must be avoided. Give your prescriber and any facilitator the same accurate list of prescribed and over-the-counter medicines, supplements, herbs, alcohol, and other substances. Tell the facilitator whether your prescriber has been consulted, so the limits of the work are clear before anything begins.
Illness, Pain, and the Embodied Journey
The path unfolds in the body, including illness, chronic pain, disability, and treatment effects. These are not detours; they shape the capacity through which practice becomes real.
Shaping capacity and practice: Conditions shape energy, mobility, and resilience. Adapt practices to the body you have today, even when that means cancelling practice or softening it substantially.
Compassionate modification beats idealized regimens. Limited capacity is not failed devotion; it is the body reporting what today’s vessel can carry.
What illness can reveal: Suffering can deepen presence, clarify what matters, cultivate empathy, and puncture fantasies of linear progress. It calls for tenderness without romanticizing pain or framing suffering as required for growth.
Do not turn illness into a purity test or pain into proof of spiritual depth.
Navigating medical systems: Appointments, procedures, and care plans become practice grounds for advocacy, emotional processing, and discernment about whose guidance you trust.
Integration, not necessarily cure: Sometimes the work is living with limitations—finding meaning and quality within real parameters.
Sometimes hope takes the form of support while symptoms remain.
The Dragon’s Path honours peak states and hospital rooms. Both belong to the path, but neither needs to be romanticized.
Medicine as Ally
Psychotropic medication can stabilize the inner world while subtly altering how experience is expressed. When the biological layer is ignored, those shifts get misread as character flaws.
Chemistry shapes threshold, tempo, salience, and access before story catches up.
Start with chemistry: what dose changes, symptoms, and side effects are shaping this behaviour right now? Responsibility begins with an accurate read of the body; it does not end there. Once the state is named, choice, impact, and consequence still matter.
On the Dragon’s Path, rejecting needed medication to chase an “untainted” experience is not purity—it is bypass. Used consciously and under medical guidance, medication can be an ally to a path grounded in safety, capacity, and biological truth.
The crucible of flesh does not become less sacred because it needs support.
Sandeep M. Nayak et al., Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports, Pharmacopsychiatry (2021). The evidence is report-based rather than a controlled interaction trial; the precaution here is specific to classic psychedelics.↩︎
The National Institute of Mental Health notes that psychiatric medications affect people differently and describes class-specific uses, effects, and monitoring needs: NIMH, Mental Health Medications.↩︎
Muhammad Youshay Jawad et al., Can Antidepressant Use Be Associated with Emotional Blunting in a Subset of Patients with Depression? A Scoping Review of Available Literature, Human Psychopharmacology: Clinical and Experimental (2023). The review found emotional blunting to be a significant patient-reported concern but also noted the difficulty of separating a medication effect from residual depression.↩︎
The FDA distinguishes abuse, misuse, addiction, physical dependence, and withdrawal, and notes that medicine, dose, frequency, duration, condition, and patient context vary: FDA, FDA Requiring Boxed Warning Updated to Improve Safe Use of Benzodiazepine Drug Class.↩︎
Sarah Reeve, Kate Robbins, and Jo Hodgekins, The Psychological Consequences of the Sedating Side Effects of Antipsychotic Medication: A Systematic Review, Psychiatry Research (2025). The review found limited but consistent evidence that sedation can affect daily functioning and motivation.↩︎